Tenaya Therapeutics
TNYA
91 hedge funds and large institutions have $55.6M invested in Tenaya Therapeutics in 2025 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 14 increasing their positions, 32 reducing their positions, and 17 closing their positions.
463% more call options, than puts
Call options by funds: $693K | Put options by funds: $123K
189% more capital invested
Capital invested by funds: $19.3M → $55.6M (+$36.3M)
18% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 17
2% more funds holding
Funds holding: 89 → 91 (+2)
1.83% more ownership
Funds ownership: 19.37% → 21.2% (+1.8%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
56% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$3.85M |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$469K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$465K |
| 4 |
Two Sigma Investments
New York
|
+$439K |
| 5 |
RBI
Raiffeisen Bank International
Vienna,
Austria
|
+$353K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.59M |
| 2 |
BlackRock
New York
|
-$409K |
| 3 |
Squarepoint
New York
|
-$350K |
| 4 |
Jane Street
New York
|
-$221K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$193K |
TNYA Hedge Fund Activity: Q3 2025 in Review
91 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q3 2025, worth a combined $55.6M — up 189% from $19.3M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new TNYA positions and 17 closed out — a net gain of 3 holders — while 14 added to existing stakes and 32 trimmed.
The largest buyer was Millennium Management, adding an estimated $3.85M. The largest seller was AQR Capital Management, cutting an estimated $1.59M.
- 91 institutional investors held Tenaya Therapeutics (TNYA) as of Q3 2025, up from 89 in Q2 2025.
- Funds reported $55.6M of Tenaya Therapeutics stock for Q3 2025, up 189% quarter-over-quarter.
- 20 funds opened new Tenaya Therapeutics positions in Q3 2025 and 17 closed out, a net change of +3 holders.
- The largest Tenaya Therapeutics buyer in Q3 2025 was Millennium Management, an estimated $3.85M added.
- The largest Tenaya Therapeutics seller in Q3 2025 was AQR Capital Management, an estimated $1.59M sold.
Based on aggregated 13F filings for Q3 2025.